Latest Insider Transactions at Biolife Solutions Inc (BLFS)
This section provides a real-time view of insider transactions for Biolife Solutions Inc (BLFS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOLIFE SOLUTIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOLIFE SOLUTIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
936
-0.21%
|
$18,720
$20.62 P/Share
|
|
Mar 29
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
390
-0.32%
|
$7,800
$20.62 P/Share
|
|
Mar 29
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
741
-0.27%
|
$14,820
$20.62 P/Share
|
|
Mar 23
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.56%
|
$210,000
$21.79 P/Share
|
|
Mar 23
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.43%
|
$20,000
$2.06 P/Share
|
|
Mar 22
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.56%
|
$210,000
$21.44 P/Share
|
|
Mar 22
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.43%
|
$20,000
$2.06 P/Share
|
|
Mar 22
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
310
-0.45%
|
$6,510
$21.84 P/Share
|
|
Mar 20
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-12.79%
|
$200,000
$20.64 P/Share
|
|
Mar 20
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
938
+1.19%
|
$1,876
$2.06 P/Share
|
|
Mar 07
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
175
-0.14%
|
$3,850
$22.95 P/Share
|
|
Mar 07
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
549
-0.12%
|
$12,078
$22.95 P/Share
|
|
Mar 07
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
31
-0.04%
|
$682
$22.95 P/Share
|
|
Mar 07
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
415
-0.15%
|
$9,130
$22.95 P/Share
|
|
Mar 01
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
844
-1.42%
|
$18,568
$22.75 P/Share
|
|
Mar 01
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,576
-2.0%
|
$34,672
$22.75 P/Share
|
|
Mar 01
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
874
-0.73%
|
$19,228
$22.75 P/Share
|
|
Mar 01
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,022
-2.32%
|
$22,484
$22.75 P/Share
|
|
Mar 01
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
903
-2.08%
|
$19,866
$22.75 P/Share
|
|
Mar 01
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
4,290
-0.94%
|
$94,380
$22.75 P/Share
|
|
Mar 01
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
1,203
-0.96%
|
$26,466
$22.75 P/Share
|
|
Mar 01
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,086
-0.76%
|
$45,892
$22.75 P/Share
|
|
Feb 21
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
133
-0.22%
|
$2,793
$21.47 P/Share
|
|
Feb 21
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
117
-0.15%
|
$2,457
$21.47 P/Share
|
|
Feb 09
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
58
-0.05%
|
$1,392
$24.6 P/Share
|
|
Feb 09
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
55
-0.12%
|
$1,320
$24.6 P/Share
|
|
Feb 09
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
144
-0.03%
|
$3,456
$24.6 P/Share
|
|
Feb 09
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
56
-0.13%
|
$1,344
$24.6 P/Share
|
|
Feb 09
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
81
-0.06%
|
$1,944
$24.6 P/Share
|
|
Feb 09
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
78
-0.03%
|
$1,872
$24.6 P/Share
|
|
Feb 08
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
9,000
-7.02%
|
$225,000
$25.13 P/Share
|
|
Feb 08
2023
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+6.56%
|
$18,000
$2.06 P/Share
|
|
Feb 07
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.83%
|
$25,000
$25.29 P/Share
|
|
Feb 07
2023
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.82%
|
$2,000
$2.06 P/Share
|
|
Feb 02
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-1.77%
|
$240,000
$24.43 P/Share
|
|
Feb 02
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.72%
|
$20,000
$2.06 P/Share
|
|
Feb 01
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.52%
|
$220,000
$22.87 P/Share
|
|
Feb 01
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.4%
|
$20,000
$2.06 P/Share
|
|
Jan 23
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
3,500
-2.85%
|
$87,500
$25.01 P/Share
|
|
Jan 23
2023
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+2.77%
|
$7,000
$2.06 P/Share
|
|
Jan 23
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
1,000
-2.25%
|
$25,000
$25.02 P/Share
|
|
Jan 19
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
374
-0.84%
|
$8,228
$22.93 P/Share
|
|
Jan 19
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
538
-1.2%
|
$11,836
$22.93 P/Share
|
|
Jan 19
2023
|
Roderick De Greef President and CEO |
BUY
Open market or private sale
|
Direct |
3,801
+8.65%
|
$87,423
$23.19 P/Share
|
|
Jan 18
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
3,000
-6.25%
|
$75,000
$25.04 P/Share
|
|
Jan 18
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,500
-5.17%
|
$162,500
$25.04 P/Share
|
|
Jan 18
2023
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+4.91%
|
$13,000
$2.06 P/Share
|
|
Jan 11
2023
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
258
-0.53%
|
$5,418
$21.94 P/Share
|
|
Jan 04
2023
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,647
+18.0%
|
-
|
|
Jan 04
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-1.91%
|
$180,000
$18.1 P/Share
|